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Abstract 51 
Pulmonary rehabilitation (PR) remains grossly underutilized by suitable 52 
patients worldwide. We investigated whether home-based maintenance tele-53 
rehabilitation will be as effective as hospital-based maintenance rehabilitation and 54 
superior to usual care in reducing the risk for acute COPD exacerbations (AECOPD), 55 
hospitalizations and emergency department (ED) visits.  56 
Following completion of an initial 2-month PR program this prospective, 57 
randomized controlled trial (between 12/2013 and 07/2015) compared 12-months of 58 
home-based maintenance tele-rehabilitation (n=47) to 12-months of hospital-based, 59 
outpatient, maintenance rehabilitation (n=50) and also to 12-months of usual care 60 
treatment (n=50) without initial PR. 61 
In a multivariate analysis during the 12-month follow-up, both home-based 62 
tele-rehabilitation and hospital-based PR remained independent predictors of a lower 63 
risk for: i) AECOPD [incidence rate ratio (IRR) 0.517 (95% CI:0.389-0.687) and IRR 64 
0.635 (95% CI:0.473-0.853)], respectively, and ii) hospitalizations for AECOPD [IRR 65 
0.189 (95% CI:0.100-0.358) and IRR 0.375 (95% CI:0.207-0.681)], respectively. 66 
However, only home-based maintenance tele-rehabilitation and not hospital-based, 67 
outpatient, maintenance PR was an independent predictor of ED visits [IRR 0.116 68 
(95% CI: 0.072-0.185). 69 
Home-based maintenance tele-rehabilitation is equally effective to hospital-70 
based, outpatient, maintenance PR, in reducing the risk for AECOPD and 71 
hospitalizations. In addition, it encounters a lower risk for ED visits, thereby 72 
constituting a potentially effective alternative strategy to hospital-based, outpatient, 73 
maintenance PR (Clinical Trials.Gov. ID: NCT02618746). 74 
 75 
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Introduction 76 
The benefits of pulmonary rehabilitation (PR) in terms of improvement in 77 
functional capacity, limb muscle function, chronic dyspnea and emotional function 78 
are well documented [1]. However, these benefits are often lost over the subsequent 79 
12 months without the implementation of a maintenance strategy [1, 2]. Few 80 
investigations have explored maintenance strategies to sustain the benefits of PR over 81 
the longer term; these results remain equivocal in regard to the duration that 82 
functional capacity and quality of life are preserved [3-6].  The effect of these long-83 
term strategies to reduce the risk for acute exacerbations of COPD (AECOPD), 84 
hospitalizations, and emergency department visits (ED) also remains inconclusive [3, 85 
4, 6, 7]. A recent meta-analysis of ten randomized controlled trials (including both 86 
short- and long-term PR maintenance strategies) [7] demonstrated that PR, when 87 
compared to usual care, is associated with lower overall rates of hospitalizations 88 
attributable to AECOPD.  89 
Despite the well documented benefits of PR [1], long-term access and 90 
utilization of PR by eligible COPD patients remains low due to insufficient funding, 91 
resources, reimbursement and other patient-related barriers limiting long-term access 92 
to PR [8]. Accordingly, alternative approaches (such as tele-rehabilitation) to extend 93 
the initial benefits of PR for a longer term, were recently recommended by the 94 
Official ATS/ERS Policy Statement [8]. 95 
Tele-rehabilitation involves the use of information and communication 96 
technologies to provide rehabilitation services remotely to people in their homes [9]. 97 
In contrast to traditional centre-based programs, undertaking PR within the home 98 
environment might promote more effective, longer term integration of exercise 99 
routines into daily life [10]. Whilst there is still little evidence of the benefits of tele-100 
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rehabilitation [1], initial small-scale studies, most of which uncontrolled, demonstrate 101 
some feasibility.  These data suggest that clinical benefits such as compliance, patient 102 
empowerment to physical training, improved health status and quality of life might be 103 
achieved [10-14]. Although these look promising, these interventions had numerous 104 
limitations such as a short duration intervention (2-6 months), high dropout rates (up 105 
to 45%), small patient numbers (n≤10) or poor adherence to different components of 106 
tele-rehabilitation [10-13, 15-17]. 107 
Consequently, more evidence is needed to ascertain the effectiveness of home-108 
based maintenance tele-rehabilitation in reducing the risk for AECOPD, 109 
hospitalizations and ED visits, whilst maintaining the functional benefits of primary 110 
PR. In the present prospective study we hypothesized that regular home monitoring of 111 
vital signs, in combination with tele-consultation sessions encouraging patient 112 
adherence to physical training regimes, would be as effective as hospital-based, 113 
outpatient, maintenance rehabilitation and superior to usual care in reducing the risk 114 
for AECOPD, hospitalizations and ED visits over a 12-month period. 115 
 116 
 117 
 118 
Methods and Materials 119 
Study design 120 
As shown in Figure 1, 150 COPD patients were randomized into three groups 121 
using a set of computer-generated random numbers to either home-based maintenance 122 
tele-rehabilitation (group A, n=50), hospital-based, outpatient, maintenance 123 
rehabilitation (group B, n=50) or usual care treatment (group C, n=50), (Clinical 124 
Trials. Gov. ID: NCT02618746). During the period spanning from December 2013 to 125 
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July 2015, patients in groups A and B initially completed a multidisciplinary intense 126 
hospital-based, outpatient, PR program lasting for 2 months (see online supplement 127 
[18]) that was followed by a 12-month maintenance rehabilitation program at home 128 
(Group A) or at Hospital (Group B). Patients in group C followed the usual care 129 
treatment throughout the 14 month period, without participation to either the 2-month 130 
primary or the 12-month maintenance programs (Figure 1). In Greece only few 131 
University Medical Departments deliver PR. Hence, the majority of COPD patients 132 
follow usual care only, which is associated with high costs for treating AECOPD. The 133 
present study was designed to investigate the value of delivering and maintaining the 134 
benefits of initial PR in comparison to usual care. Thus, in order to balance the 135 
observation period between the three groups, we performed all measurements in 136 
group C at the same time points as in the other two groups (i.e. months 0, 2 and 14). 137 
Study subjects 138 
One hundred and fifty (150) clinically stable patients that regularly attending the 139 
Outpatient Clinic (1st Department of Respiratory Medicine at Athens University 140 
Medical School based at Sotiria General Chest Hospital) were recruited. Patients 141 
(n=150) were included in the study if they were older than 40 years; with a diagnosis 142 
of COPD (post-bronchodilation FEV1/FVC<0.7) with moderate to very severe airflow 143 
obstruction (post-bronchodilator FEV1 <80% pred.); with optimal medical treatment 144 
according to GOLD [19] without regular use of systemic corticosteroids; and a history 145 
of AECOPD one year prior to entering the study. Patients were excluded from the 146 
study based on the diagnosis of orthopedic, neurological and other conditions that 147 
significantly impair exercise tolerance, or respiratory disorders other than COPD. 148 
Patients were also excluded on grounds of cognitive impairment and/or difficulties to 149 
managing electronic devices that precluded interactions with the tablet, as judged by 150 
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the investigator. More details on the exclusion criteria are provided in the online 151 
supplement. The majority of patients were referred to the PR program because of 152 
persistent respiratory symptoms, but also following hospitalization for AECOPD (4 153 
patients in Group A and 6 patients in Group B). These patients were included in the 154 
study at least 8 weeks after the hospitalization [19]. None of these patients had 155 
previously participated in a PR program. The Scientific Board of Clinical Studies at 156 
Sotiria Hospital approved the study protocol (approval number: 22964). 157 
Description of interventions 158 
Home-based maintenance tele-rehabilitation program (Group A) 159 
The home-based maintenance tele-rehabilitation program consisted of 144 160 
sessions performed over 12 months. The program included the following components: 161 
a) individualized action plan; b) physical exercise sessions to remote monitoring; c) 162 
access to the call center 5 days/week - 10 hrs/day; d) psychological support; and e) 163 
dietary and self-management advice via scheduled weekly contacts with a 164 
physiotherapist, an exercise scientist, a dietician and a physician through telephone or 165 
a video conference. During the course of the 2-month initial PR program, patients 166 
were trained to appropriately use the multimodal apparatus (MIR Spirodoc, 167 
Spirodoc®, Spiro+Oxi, Roma, Italy), that was subsequently used to make 168 
measurements at home. Training enabled the patients to take their own spirometry and 169 
vital sign measurements using a wireless apparatus fitted with Bluetooth technology. 170 
Patients were also taught to successfully transfer the data to a tablet placed in their 171 
home (Lenovo Smart Tab II7, Bratislava, Slovakia) and transmit the data from the 172 
tablet to a secured web-based platform via a mobile communications network. The 173 
home-based exercise program was comprised of arm and leg exercises, as well as 174 
walking drills. Exercises were individually tailored to address each patient’s specific 175 
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requirements and adapted as required by an exercise scientist. A video demonstration 176 
of the home exercises was installed on to the tablet to provide patients with a resource 177 
to correctly execute the exercises. Exercise vital sign data (heart rate and oxygen 178 
saturation) along with ratings relating to the symptoms of dyspnea and leg discomfort, 179 
were recorded by patients immediately after completion of the home exercise 180 
program.  These data were transmitted to the web-based platform on three specific 181 
days every week for 12 months. The remainder of the data, namely daily steps 182 
captured by a pedometer, spirometry, oximetry and responses to questionnaires 183 
(HRQoL, CAT, HADS, mMRC) were recorded and transmitted twice weekly for 12 184 
months. Patients were asked to complete the HADS questionnaire once every month. 185 
Data were transmitted from the tablet to a secure web-based server platform 186 
[(TELECARE (version 2.2.13): Linkcare Health Services SL, Barcelona, Spain; 187 
incorporated and adapted by Singularlogic Integrator S.A., Athens, Greece)] [20]. 188 
Data were stored on the web-based platform and reviewed regularly (three to four 189 
times per week) by the different health care professionals (see online supplement for 190 
further details). 191 
Hospital-based, outpatient, maintenance rehabilitation program (Group B) 192 
Patients assigned to the hospital-based PR program visited the hospital twice 193 
weekly for 12 months in order to participate to a multidisciplinary maintenance 194 
rehabilitation program including exercise training, physiotherapy, dietary and 195 
psychological advice [18] (see online supplement). The hospital-based maintenance 196 
rehabilitation program consisted of 96 sessions performed over 12 months. 197 
Usual care  198 
Usual care, included optimal pharmacotherapy oxygen therapy in the presence 199 
of respiratory failure, vaccination for S. pneumoniae, annual vaccination for 200 
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influenza, and regular follow up by a respiratory physician according to the guidelines 201 
[19]. Furthermore, patients were trained on the early recognition of an AECOPD in 202 
order to be able to seek for timely medical care.  203 
Study Procedures 204 
For groups A and B outcome assessment was conducted at baseline, 205 
immediately after completion of the primary 2-month PR program and 12 months 206 
later. For group C outcomes were assessed at the respective time points as groups A 207 
and B (Figure 1). The primary end point was the rate of moderate to severe AECOPD, 208 
hospitalizations due to AECOPD and ED visits, which were compared among the 3 209 
groups over a period of 12 months following completion of the primary 2-month 210 
period. Additional analyses included the rate of severe exacerbations 211 
(hospitalizations) and the rate of ED visits due to AECOPD that did not require 212 
hospital admission. Decision for hospital admission was based on the judgment of the 213 
consultant physicians in accordance with the criteria suggested in the GOLD 214 
document [19], including the marked increase in symptom intensity (e.g. sudden 215 
development of resting dyspnea), severe underlying COPD, onset of new physical 216 
signs (e.g. cyanosis, peripheral edema), failure of an exacerbation to respond to initial 217 
medical management, presence of serious comorbidities (e.g. heart failure or new 218 
arrhythmias), frequent exacerbations, older age, and insufficient home support [19]. In 219 
regards to the ED visits, they were based on the patients’ judgment and the 220 
availability of care at the timing of the worsening of the symptoms. Secondary end 221 
points included i) functional capacity, ii) daily physical activity and iii) health-related 222 
quality of life outcomes. 223 
 224 
 225 
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Definitions of AECOPD 226 
AECOPD were defined according to the GOLD definition [19] as acute events 227 
characterized by a worsening of the patient’s respiratory symptoms that is beyond 228 
normal day-to-day variations and leaded to a change in medication. Moderate to 229 
severe AECOPD were events where patients received antibiotics, systemic 230 
corticosteroids or both. Hospitalizations (severe exacerbations) and emergency 231 
department visits (ED) due to AECOPD were also assessed. A respiratory physician 232 
with expertise in COPD (acted as case manager) was able to recognize symptom 233 
deterioration using the study web-based platform and communicated with the patients 234 
assigned to the home-based maintenance tele-rehabilitation group when needed. 235 
Patients in the other two groups (hospital-based, outpatient, maintenance and usual 236 
care) received training to be able to recognize the onset of an AECOPD and contact 237 
the study chest physicians in case of symptom deterioration. Monthly telephone 238 
contacts with the patients in all groups ensured that no AECOPD event was missing. 239 
In case patients needed hospital admission the study medical case manager was able 240 
to contact the patients’ physicians and get all information needed for the patient and 241 
the type of AECOPD. Drug prescription could be found in the electronic prescription 242 
system used by the Greek medical registration system.  243 
Outcome measures 244 
Lung function and functional capacity assessment 245 
Post-bronchodilation dynamic spirometry, diffusing capacity of the lung and 246 
evaluation of static lung volumes (see online supplement) [21] were assessed. 247 
Incremental exercise tests were performed on an electronic ergometer bicycle with 248 
breath-by-breath gas exchange measurements and cardiac output recordings, using 249 
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impedance cardiography, to the limit of tolerance (see online supplement). Functional 250 
capacity was assessed by the 6MWT [22].  251 
Daily physical activity 252 
Daily physical activity measurements were performed by using a validated for 253 
COPD patients activity monitor (Actigraph GT3X, Actilife, Pensacola, FL) [23, 24] 254 
(see online supplement). 255 
Health Related Quality of life (HRQoL) and respiratory symptoms  256 
HRQoL and respiratory symptoms were evaluated by the following 257 
questionnaires [1, 19]: a) St. George's Hospital Respiratory Questionnaire (SGRQ), b) 258 
COPD assessment questionnaire (CAT) and c) modified Medical Research Council 259 
dyspnea scale (mMRC). 260 
Analysis of adherence rates (compliance) 261 
Adherence to the home-based maintenance tele-rehabilitation and hospital-262 
based, outpatient, maintenance programs were assessed by the adherence rate (actual 263 
number of sessions/total expected number of session*100). Adherence to 264 
measurements of vital signs, home exercises, responses to questionnaires and daily 265 
steps were recorded by the number of registrations entered divided by the number of 266 
those recommended, for each participant (see online supplement for more details). 267 
Sample size calculations 268 
The calculation of sample size was based on ANOVA repeated measurements 269 
between the three groups. The minimum detectable difference in the number of 270 
hospitalizations for AECOPD was used for the power calculation, which was obtained 271 
from a previous study [25]. This previous work evaluated the effect of a PR program 272 
on the frequency of hospitalization during 1 year after completion of the initial PR 273 
program compared with 1 year before PR. An effect size of 0.42, based on a mean 274 
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difference (1.37) and SD (3.26) of AECOPD/year [25], estimated a sample size of 116 275 
patients was required to achieve a power of 0.90 using an alpha significance level of 276 
0.05 (2-sided). To compensate for a potential dropout rate of 20%, a total sample size 277 
of 138 patients (46 patients in each group) was determined to be sufficient. Sample 278 
size calculation was performed by GPower 3.1.7 software. During the 2-month 279 
primary PR program, 3 patients from group A were discontinued from the study due 280 
to transport barriers. 281 
Statistical Analysis 282 
The Shapiro-Wilk test revealed that all data were normally distributed. One-283 
way ANOVA was utilized to detect differences among the 3 groups at baseline for all 284 
variables. Group differences were investigated by two-way ANOVA with repeated 285 
measurements at different time points, namely baseline, 2 months and 14 months after 286 
patient enrolment to the study. Where necessary, significance differences were 287 
followed up with pair-wise Tukey’s post-hoc analyses. Time to first AECOPD, 288 
hospitalization for AECOPD and ED visit for each group were evaluated by Kaplan-289 
Meier survival curves and log-rank tests. Poisson regression univariate and 290 
multivariate analyses were performed in order to evaluate the influence of the 291 
participation in hospital-based, outpatient, PR or home-based tele-rehabilitation 292 
programs, AECOPD, hospitalizations for AECOPD and visits to emergency 293 
department (ED) in the 1-year of follow-up. Results are presented as hazard ratios 294 
(HR) with 95% confidence intervals (CI). Poisson regression univariate and 295 
multivariate analyses were additionally performed in order to account for variability 296 
in exacerbation rates between patients. Skewed data were logarithmically transformed 297 
for regression analyses. P-values <0.05 were considered statistically significant. Data 298 
were analyzed using SPSS 22.0 for Windows (SPSS Inc., Chicago, IL, USA). 299 
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Results 300 
AECOPD, hospitalizations and ED visits 301 
Patients’ demographic and clinical characteristics at baseline are shown in 302 
Table 1. Both the home-based maintenance tele-rehabilitation group and the hospital-303 
based group showed a lower rate p<0.001 of AECOPD and hospitalizations for 304 
AECOPD in the 12 months of follow-up compared to the usual care group 305 
[(mean±SD) 1.7±1.7 vs 1.8±1.4 vs 3.5±1.8; respectively]. Similarly, the rates of 306 
hospitalizations for AECOPD were lower in the home-based tele-rehabilitation group 307 
and the hospital-based group compared to usual care (0.3±0.7, 0.3±0.6 vs 1.2±1.7, 308 
respectively, p<0.001). Finally, the home-based tele-rehabilitation group showed 309 
lower rate of ED visits in the 12 months of follow-up compared to both the hospital-310 
based group and the usual care group (0.5±0.9 vs 1.8±1.5 vs 3.5±1.8, respectively, 311 
p<0.001). 312 
Kaplan-Meier survival curves evaluating the time to next AECOPD and 313 
hospitalizations for AECOPD in the 12 months of follow-up are presented in Figure 2. 314 
In the univariate Poisson regression analysis, significant predictors of AECOPD were 315 
smoking status, FEV1 (% predicted), number of AECOPD in the preceding year and 316 
PR (either home-based maintenance tele-rehabilitation or hospital-based, outpatient, 317 
maintenance rehabilitation; Table 2). Accordingly, significant predictors of 318 
hospitalizations for AECOPD were gender, FEV1 (% predicted), number of AECOPD 319 
in the preceding year, and PR (either hospital-based, outpatient, maintenance PR or 320 
home-based maintenance tele-rehabilitation; Table 2). In multivariate analysis, PR 321 
(both home-based tele-rehabilitation and hospital-based, outpatient rehabilitation) 322 
remained an independent predictor of a lower risk for AECOPD in the 12-month 323 
follow up [incidence rate ratio (IRR) 0.517 (95%CI 0.389-0.687), p<0.001] and [IRR 324 
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0.635 (95%CI 0.473-0.853), p=0.003] for the home-based maintenance tele-325 
rehabilitation and hospital-based, outpatient, maintenance PR groups, respectively. In 326 
addition, PR (both home-based maintenance tele-rehabilitation and hospital-based 327 
maintenance rehabilitation) remained an independent predictor of a lower risk for 328 
hospitalizations for AECOPD [IRR 0.189 (95%CI 0.100-0.358), p<0.001] and [IRR 329 
0.375 (95%CI 0.207-0.681), p=0.001] for home-based maintenance tele-rehabilitation 330 
and hospital-based maintenance PR, respectively. However, only home-based 331 
maintenance tele-rehabilitation and not hospital-based maintenance PR was an 332 
independent predictor of visits in the ED [IRR 0.116 (95% CI 0.072-0.185), p<0.001; 333 
Table 2). 334 
Functional capacity  335 
Home-based maintenance tele-rehabilitation was equally effective to hospital-336 
based, outpatient, maintenance PR in preserving for 12 months the initial statistical 337 
and/or clinically meaningful improvements in peak work rate (p=0.011) and the 338 
distance covered during the 6MWT, respectively and were superior to usual care 339 
(Table 3). The magnitude of improvement induced by the primary 2-month PR 340 
program in the aforementioned variables was not different between groups A and B. 341 
Following the initial PR program the fraction of patients who improved beyond the 342 
MCID (>25 m) the 6MWT was for Group A: 53%, Group B: 60% and Group C: 4%. 343 
HRQoL, respiratory symptoms and chronic dyspnea 344 
Home-based maintenance tele-rehabilitation was equally effective to hospital-345 
based, outpatient, maintenance rehabilitation in preserving the initial clinically 346 
meaningful improvement in SGRQ, CAT and mMRC scores over a period of 12-347 
months and was superior to usual care exhibiting deterioration in the questionnaire 348 
scores over the same period (Table 4). The magnitude of improvement induced by the 349 
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primary 2-month PR program in the aforementioned parameters was not different 350 
between the two rehabilitation groups.  351 
Daily physical activity 352 
Home-based maintenance tele-rehabilitation was equally effective to hospital-353 
based maintenance, outpatient, PR in preserving the initial improvement in time spent 354 
in sedentary, light, lifestyle and moderate daily physical activities over the 12-month 355 
period, and was superior to usual care exhibiting an increase in time spent in 356 
sedentary, and decrease in lifestyle, and moderate daily activities over 12 months 357 
follow up (Figure 3: on line supplement). 358 
Adherence/Compliance 359 
The overall compliance to the different components of the home-based 360 
maintenance tele-rehabilitation intervention (Figure 4: online supplement) over 12-361 
months follow up was 93.5%.  362 
 363 
Discussion 364 
The main finding of the study was that home-based maintenance tele-365 
rehabilitation via monitoring of vital signs was as effective as hospital-based, 366 
outpatient, maintenance PR and superior to usual care in terms of reducing the risk for 367 
AECOPD and hospitalizations, whilst preserving the functional and HRQoL benefits 368 
of a primary PR program over a period of 12 months. Moreover, only home-based 369 
maintenance tele-rehabilitation and not hospital-based, outpatient, maintenance PR 370 
was an independent predictor of reduced risk for ED visits. 371 
Recently an international task force commissioned by the ATS and ERS 372 
delivered policy recommendations to improve access and delivery of PR services to 373 
suitable patients [8]. It was recognized that although traditional models of outpatient 374 
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PR are suitable for many patients, several barriers prevent the vast majority of eligible 375 
patients to access or adhere to these programs, particularly in regions or healthcare 376 
systems where traditional models of PR are not feasible [8]. It was, thus, 377 
recommended that research should focus on the effectiveness of alternative models of 378 
PR such as tele-rehabilitation [26].  379 
In the present study we have included a population of high-risk patients with a 380 
history of exacerbations as the majority of them experienced ED visits and 381 
hospitalizations during the study, in accordance with previous observations in similar 382 
populations in Greece [47]. Our findings on the reduction of the risk for AECOPD for 383 
both home-based maintenance tele-rehabilitation and hospital-based maintenance 384 
strategies are consistent with previous RCT studies [27, 28] employing comparable 385 
protocols of initially intense PR programs followed by home maintenance sessions. In 386 
addition, our results on the reduction of risk for hospitalizations for AECOPD concur 387 
with those [27-29] applying long-term follow-up maintenance strategies. Importantly, 388 
our findings on the reduction of the overall rate of hospitalizations for AECOPD per 389 
person/year at risk for the home-based maintenance tele-rehabilitation group [by 0.19 390 
(0.10-0.35)] as well as for the hospital-based, outpatient, maintenance program [by 391 
0.38 (0.21-0.68)], compare favorably with the overall rate recently reported form the 392 
meta-analysis of 10 RCT studies [by 0.62 (0.33-1.16)] [7]. Furthermore, the 393 
effectiveness of home tele-rehabilitation in reducing the risk for ED visits provides 394 
evidence that early patient and physician recognition of AECOPD followed by prompt 395 
treatment initiation prevent COPD-related health worsening [27-30]. The home-based 396 
tele-rehabilitation group had the advantage of spirometry and physical signs 397 
monitoring that may have further supported the early recognition of AECOPD. 398 
Indeed, a more prompt recognition of symptom and/or lung function deterioration 399 
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may have resulted in the prompt intervention for medical care and decreased the need 400 
for an ED visit. 401 
The economic burden of COPD increases with increasing disease severity, 402 
whilst it is substantially augmented by exacerbations and hospitalizations. A study 403 
conducted in Greece has estimated that the mean cost per severe COPD exacerbation 404 
is €1711; range: €1357 to €2614, depending on the severity [31]. These findings 405 
highlight the importance of reducing the frequency of AECOPD and hospitalizations. 406 
This is particularly important in light of findings indicating that a significant 407 
proportion of COPD patients in Greece experience two or more AECOPD/year and 408 
that the majority of these exacerbations are moderate or severe, frequently leading to 409 
hospitalizations [32]. Collectively, these findings emphasize the importance of 410 
decreasing the number of AECOPD per patient/year, in order to alleviate the disease 411 
burden as well as the economic cost of the disease. In regards to cost savings for 412 
delivering the present home-based maintenance tele-rehabilitation program over a 413 
period of 12 months, the calculated total cost per patient including equipment, 414 
development of the ICT platform, use of 3G network, and cost for personnel was 415 
approximately €1800. This figure is equivalent to approximately 60% of the total 416 
estimated cost (€2908) spared by reducing the frequency of AECOPD (by 1.7 417 
AECOPD per patient/year x €1711= €2908) [31]. In addition, this figure is 418 
approximately 40% of the estimated cost for one year of hospital-based maintenance 419 
rehabilitation sessions including twice-weekly outpatient respiratory department 420 
visits.  421 
Remote monitoring of vital signs allows clinicians to monitor a patient 422 
remotely with reference to physiological signs, respiratory symptoms and activity 423 
levels using a wide range of technological devices [10, 33-36]. In this study, we have 424 
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implemented patient tele-consultation based on vital sign data (recorded by patients 425 
using portable devices) transmitted to an ICT web based platform via patients’ tablets. 426 
In addition, patients were provided with feedback to maintain progress in respect to 427 
executing home exercise drills and enhancing daily activity levels. Accordingly, we 428 
have described a novel home-based maintenance tele-rehabilitation approach to 429 
reduce the risk for AECOPD and hospitalizations for AECOPD to a similar extent of 430 
a hospital-based maintenance rehabilitation program. 431 
The home-based maintenance tele-rehabilitation program was not by any 432 
means inferior to the supervised hospital-based, outpatient, maintenance PR program 433 
in preserving true physiological training effects, respiratory symptoms, daily activity 434 
levels and aspects of quality of life over a period of 12 months. Previous studies have 435 
also reported positive effects of hospital-based maintenance PR programs on exercise 436 
capacity and quality of life [6]. However, insufficient funding, resources, and 437 
reimbursement limit the implementation of such hospital-based programs worldwide 438 
[8]. To the best of our knowledge, this is the first study to show that home-based 439 
rehabilitation with the use of ICT is effective in preserving the long-term 440 
physiological training effects initially acquired by a comprehensive hospital-based PR 441 
program. Nevertheless, future studies by healthcare professionals are required to 442 
inform and disseminate information on the costs, clinical- and cost-effectiveness of 443 
maintenance rehabilitation programs to payers [8]. Patients assigned to the usual care 444 
group not undertaking the initial 2-month outpatient PR program and subsequently the 445 
12-month maintenance program experienced significant deterioration in functional 446 
capacity and quality of life, further highlighting the beneficial effects of PR 447 
maintenance strategies [27-29].  448 
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The finding that home-based maintenance tele-rehabilitation preserved the 449 
initial physiological benefits deserves further analysis to justify these findings. 450 
Potential factors may include [36]: i) excellent patient adherence to regular vital sign 451 
recordings (Figure 4), ii) very good compliance to home exercise drills, iii) patient 452 
empowerment in the promotion of high levels of daily physical activity, iv) regular 453 
feedback on patient’s progress through motivation messages to tablets or via 454 
telephone contacts and v) adherence to sufficient exercise training loads and self-455 
management techniques. Indeed, regular investigators-patient communications 456 
facilitated their empowerment in the promotion of increased levels of physical activity 457 
and raised their awareness to comply with the measurement and physical activity 458 
requirements of the protocol. 459 
Incomplete implementation of the aforementioned factors as well as 460 
inadequate sample size power [37-39] most likely explains why previously 461 
implemented tele-rehabilitation studies did not demonstrate such long-term benefits 462 
[38, 40, 41]. Combining self-management techniques, regular exercise training and 463 
contact with the PR personnel has likely contributed to reinforce behavioral changes 464 
towards a more active lifestyle [42]. Our findings support this notion since the 465 
combination of home physical training, physical activity consultation and 466 
personalized feedback on weekly physical activity levels decreased the time spent in 467 
sedentary activities and improved the time spent in light and moderate lifestyle 468 
activities [43]. Given that low levels of daily physical activity is a independent risk 469 
factor for AECOPD [42], it is plausible that maintenance of enhanced daily physical 470 
activity over a period of 12 months could have contributed to the reported reduced 471 
risk for AECOPD.  This is an important outcome since earlier studies including a 472 
recent systematic review with meta-analyses [15-17] highlight the finding that tele-473 
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healthcare interventions have minimal impact on patients’ physically active time.  474 
Our findings are in tandem with those of Hoaas et al. who showed that 475 
following completion of an initial (4-week) supervised PR program, improvements in 476 
6MWT and quality of life were preserved for one year when a home tele-477 
rehabilitation program was implemented [13]. These outcomes are justified by the 478 
high adherence rate for vital sign measurements and training sessions. Indeed, our 479 
multimodal home-based tele-rehabilitation and tele-consultation program, in contrast 480 
to other studies [36, 44], resulted in very good adherence without dropouts over a 481 
period of 12 months.  482 
Study limitations 483 
Our study design was not blinded, and as such the investigators were aware of 484 
the allocation of patients into the different maintenance rehabilitation groups. 485 
Importantly, patients were given general information about their participation in the 486 
study and details on the interventions related only to their intervention arm. Moreover, 487 
the choice of objective endpoints that were related to healthcare resource use 488 
(moderate or severe AECOPD, hospitalizations and ED visits) minimizes to the best 489 
possible extent potential biases.  490 
Another potential limitation of the study is that the usual care group (C) of our 491 
study did not participate in a PR program.  PR in Greece is delivered only by few 492 
University Medical Departments. Hence, the majority of COPD patients follow usual 493 
care only, which unfortunately does not include access to PR. This is due to the lack 494 
of specialized rehabilitation centers and trained personnel. This is why our study was 495 
designed to represent the reality in the local community and provide evidence to 496 
health authorities of the major advantages of PR, in order to allocate an infrastructure 497 
(personnel and resources) to establish PR programs in the community or at home 498 
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across the nation.  Lack of access for the usual care group to the initial 2-month PR 499 
program may therefore constitute a limitation as one could argue that maintenance of 500 
benefits might be, at least in part, related to the conduction of initial PR, which 501 
brought benefits to only those patients who undertook PR. However, it is well 502 
documented that benefits of PR are often lost over a period of 12 months without 503 
implementation of a maintenance strategy [1-6]. Hence, an important aspect of our 504 
study was to identify the best maintenance strategy to preserve the initial benefits of 505 
PR for an extended period. 506 
The hospital-based, outpatient, maintenance program was conducted at the 507 
hospital’s gymnasium using specialized equipment (e.g. stationary bicycles and 508 
weight lifting apparatus), whilst the home-based exercise program was comprised by 509 
arm and leg exercises, as well as walking drills without use of any specialized 510 
equipment. This is the reason why we offered three weekly sessions at home (as 511 
opposed to two sessions during the outpatient hospital-based maintenance program) in 512 
an attempt to ensure adequate weekly physical exercise in this group. This difference 513 
in the total number of maintenance sessions between the two maintenance strategies 514 
over the 12-month follow up period could have potentially introduced bias. 515 
Nevertheless, our finding that the home-based maintenance tele-rehabilitation 516 
program was equally effective to the hospital-based, outpatient, maintenance PR in 517 
preserving for 12 months the initial statistical and/or clinically meaningful 518 
improvements in peak work rate and the 6MWT, respectively suggest that the applied 519 
overall training load was well matched between the hospital-based and the home-520 
based groups.  521 
The incidence of AECOPD is often related to multiple factors, including 522 
appropriate care by the attending physicians, adherence to treatment [45, 46], and co-523 
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morbidities that include anxiety and depression [47] and cardiovascular comorbidities 524 
[48]. However, we have attempted to delimit the impact of such confounding factors 525 
during the study, as all patients were prescribed optimal treatment for COPD and co-526 
existent conditions, received appropriate training on the use of inhaled medication and 527 
were optimally followed-up by respiratory physicians.  528 
Clinical implications 529 
Application of home-based maintenance tele-rehabilitation programs may lead 530 
to significant reductions of healthcare resource use for patients with COPD compared 531 
to usual care, with potential benefits on patients’ outcomes and quality of life. 532 
Conclusions 533 
Home-based maintenance tele-rehabilitation is equally effective to hospital-534 
based, outpatient, maintenance PR, in reducing the risk for AECOPD and 535 
hospitalizations and encounters a lower risk for ED visits, thereby potentially 536 
constituting an effective alternative strategy to hospital-based, outpatient, 537 
maintenance rehabilitation. 538 
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Table 1. Patients’ demographic and clinical characteristics at baseline 549 
 Group A Group B Group C 
 (n=47) (n=50) (n=50) 
Men/women, n/n 44/3 38/12 37/13 
Age, years 66.9±9.6 66.7±7.3 64.0±8.0 
FEV1, L 1.55±0.80 1.41±0.48 1.42±0.66 
FEV1, % pred 49.6±21.9 51.8±17.3 51.7±21.0 
FVC, L 3.07±0.90 2.70±0.65 2.77±0.81 
FVC, %pred 80.7±20.2 78.4±18.4 80.0±20.3 
FEV1/FVC, % 47.0±14.1 49.0±12.7 51.9±12.4 
VC, %pred 83.6±20.6 85.5±14.6 82.6±21.9 
IC, %pred 81.7±33.0 77.3±30.0 76.9±31.0 
TLC, %pred 118.8±30.3 120.7±25.7 119.9±28.8 
FRC, %pred 158.5±60.5 154.5±43.0 154.4±56.6 
RV, %pred 184.6±80.6 180.2±59.9 182.0±70.9 
DLCO, %pred 53.5±19.9 57.0±20.4 55.9±28.4 
SpΟ2,% 93.0±3.0 94.0±2.9 94.0±3.0 
6MWT, m 389.1±91.3 385.1±80.3 384.8±80.2 
Body mass 
index, kg/m2 28.0±5.3 27.5±5.0 26.4±5.0 
BODE index 3.5±2.7 3.2±2.1 3.3±2.3 
mMRC 2.3±1.0 2.5±1.0 2.2±1.1 
Oxygen therapy 
(LTOT) 13 9 15 
Smoking status 
(cur. vs ex.) 7/40 4/46 3/47 
Drug therapy    
LAMA 36 37 35 
LABA 22 26 24 
ICS 32 37 41 
Comorbidities    
≥1 comorbidity    
Cardiovascular 14 15 13 
Number of 
AECOPD 3.3±1.3 3.4±1.4 3.3±1.6 
    
 550 
Values are mean±SD. Abbreviations: FEV1: forced expiratory volume in 1 s; FVC: forced 551 
vital capacity; FEV1/FVC: forced expiratory volume (FEV1)/forced vital capacity (FVC); 552 
VC(%predicted): vital capacity; IC(%predicted): inspiratory capacity; TLC(%predicted): total 553 
lung capacity; FRC(%predicted): residual capacity; RV(%predicted): reserve volume; 554 
DL,CO(%predicted): diffusion capacity; SpO2(%): oxygen saturation; 6MWT: six minute walk 555 
test. mMRC: modified Medical Research Council dyspnea scale; LAMA: Long-Acting 556 
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Muscarinic Agonists; LABA: Long-Acting Beta-Agonists; ICS: inhaled corticosteroids.  557 
Group A: home-based maintenance tele-rehabilitation; Group B: hospital-based, outpatient, 558 
maintenance rehabilitation and Group C: usual care. 559 
 560 
 561 
 562 
 563 
 564 
 565 
 566 
 567 
 568 
 569 
 570 
 571 
 572 
 573 
 574 
 575 
 576 
 577 
 578 
 579 
 580 
 581 
 582 
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Table 2.Predictors of AECOPD, hospitalizations and ED visits 583 
 Univariate analysis Multivariate analysis 
 IRR 95% CI p-value IRR 95% CI p-value 
AECOPD        
Age  1.001 0.987-1.014 0.069    
Gender (female) 1.225 0.942-1.595 0.131    
Smoking status (ex-smoker) 1.727 1.170-2.550 0.006 1.045 0.694-1.573 0.833 
FEV1 (%pred) 0.985 0.979-9.991 <0.001 0.992 0.986-0.999 0.016 
n AECOPD/preceding year 1.164 1.125-1.203 <0.001 1.148 1.098-1.201 <0.001 
Group A 0.562 0.429-0.737 <0.001 0.517 0.389-0.687 <0.001 
Group B 0.498 0.375-0.660 <0.001 0.635 0.473-0.853 0.003 
Group C (indicator)       
Hospitalizations for 
AECOPD  
      
Age  1.002 0.975-1.030 0.877    
Gender (female) 0.497 0.248-0.997 0.049 0.475 0.208-0.871 0.019 
Smoking status (ex-smoker) 1.523 0.732-3.170 0.261    
FEV1 (%pred) 0.979 0.960-0.986 <0.001 0.981 0.967-0.995 0.008 
n AECOPD/preceding year 1.171 1.096-1.251 <0.001 1.160 1.051-1.280 0.003 
Group A 0.268 0.149-0.482 <0.001 0.189 0.100-0.358 <0.001 
Group B 0.292 0.165-0.518 <0.001 0.375 0.207-0.681 0.001 
Group C (indicator)       
ED visits for AECOPD        
Age  0.990 0.975-1.005 0.191    
Gender (female) 1.536 1.162-2.031 0.003 1.051 0.772-1.431 0.752 
Smoking status (ex-smoker) 1.964 1.242-3.105 0.004 0.815 0.504-1.318 0.404 
FEV1 (%pred) 0.987 0.980-0.994 <0.001 0.992 0.984-0.994 0.027 
n AECOPD/preceding year 1.156 1.113-1.201 <0.001 1.244 1.175-1.316 <0.001 
Group A 0.151 0.099-0.232 <0.001 0.116 0.072-0.185 <0.001 
Group B 0.501 0.380-0.661 <0.001 0.750 0.555-1.015 0.062 
Group C (indicator)       
 584 
Abbreviations: AECOPD: Acute exacerbation of COPD; ED: Emergency Department; FEV1: 585 
forced expiratory volume in 1 s; n: Number. Group A: home-based maintenance tele-586 
rehabilitation; Group B: hospital-based, outpatient, maintenance pulmonary rehabilitation and 587 
Group C: usual care. 588 
 589 
 590 
 591 
 592 
 593 
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Table 3.Changes in functional capacity 594 
 
Baseline 2-months 14-months  
 
WRpeak (Watt) 
Group A 63±33 74±35* 76±35* 
Group B 67±25 79±32* 79±31* 
Group C 65±24 63±27 58±24* 
6MWT (m)    
Group A 389.1±91.3 422.1±70.5† 420.2±74.9† 
Group B 385.1±80.3 423.0±70.5† 427.5±63.0† 
Group C 384.8±80.2 382.4±80.3 339.9±110.1† 
 595 
Values are mean±SD. Abbreviations: WRpeak: peak work rate; 6MWT: the distance 596 
covered during the six minute walking test. Asterisks indicate statistically significant 597 
differences from baseline. Crosses indicate clinically meaningful differences from 598 
baseline. Group A: home-based maintenance tele-rehabilitation; Group B: hospital-based, 599 
outpatient, maintenance rehabilitation and Group C: usual care. 600 
 601 
Table 4. Changes in HRQoL, respiratory symptoms and chronic dyspnea 602 
 
Baseline 2-months 14-months  
 
SGRQ 
Group A 46.2±19.7 42.2±19.2† 38.4±20.5† 
Group B 43.5±16.7 35.4±15.7† 33.6±16.5† 
Group C 44.1±16.6 44.7±16.9   50.2±17.7† 
CAT    
Group A 17.6±8.1 12.9±7.5† 13.0±7.3† 
Group B 15.7±5.6 13.2±5.8† 11.8±5.6† 
Group C 15.8±4.9 16.1±6.2   20.9±6.7† 
mMRC    
Group A 2.3±1.0 1.8±0.9† 1.6±1.0† 
Group B 2.5±1.0 1.5±0.9† 1.3±0.9† 
Group C 2.2±1.1 2.5±1.0   3.1±0.8† 
 603 
Values are mean±SD. Abbreviations: SGRQ: Saint George Respiratory 604 
Questionnaire; CAT: COPD Assessment Test; mMRC: modified Medical Research 605 
Council. Crosses indicate clinically meaningful differences from baseline. Group A: 606 
home-based maintenance tele-rehabilitation; Group B: hospital-based, outpatient, 607 
maintenance rehabilitation and Group C: usual care. 608 
27 
 
Figure legends 609 
Figure 1. Patient flow chart providing information in regards to the study protocol. 610 
 611 
Figure 2. Percentage (%) of patients with AECOPD (Figure 2A) hospitalizations 612 
(Figure 2B) and emergency department visits (Figure 2C) during the 12 months 613 
follow up. Group A: home-based maintenance tele-rehabilitation, Group B: hospital-614 
based, outpatient, rehabilitation and Group C: usual care treatment. Note that AECOPD 615 
refers to all kind of AECOPD regardless of the place where they were treated (home, 616 
hospital or ED). 617 
 618 
Figure 3. Changes in daily physical activity levels defined by the time spend in 619 
sedentary (A), light (B), lifestyle (C) and moderate (D) activities. Values are 620 
mean±SD. Asterisks indicate statistically significant differences from baseline for the 621 
home-based maintenance tele-rehabilitation (dark grey bars) and hospital-based, 622 
outpatient,  rehabilitation (light grey bars) groups. Two asterisks indicate statistically 623 
significant differences from the 2-month time point for the usual care group (white 624 
bars). 625 
 626 
Figure 4. Patient’s compliance to the different components of monitoring and home-627 
based maintenance tele-rehabilitation maintenance program over a 12-month period 628 
(Group A, n=47). 629 
 630 
 631 
 632 
 633 
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